Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Rogler

Showing results (151-160 of 547) with videos related to

Pageof 55
Sort By:
Plos One|August 31, 2013
Protein tyrosine phosphatase non-receptor type 22 modulates NOD2-induced cytokine release and autophagyMarianne R Spalinger, Silvia Lang, Stephan R Vavricka, et al.
Digestion|March 16, 2020
Treatment Algorithms for Crohn's DiseaseMichael Christian Sulz, Emanuel Burri, Pierre Michetti, et al.
Inflammatory Bowel Diseases|July 9, 2015
Extraintestinal Manifestations of Inflammatory Bowel DiseaseStephan R Vavricka, Alain Schoepfer, Michael Scharl, et al.
European Journal of Gastroenterology & Hepatology|July 11, 2006
A new organotypic model to study cell interactions in the intestinal mucosaTanja Spottl, Martin Hausmann, Manuela Gunckel, et al.
BMJ Open|March 12, 2015
VAlidation of an 8-item-questionnaire predictive for a positive caLprotectin tEst and Real-life implemenTation in primary care to reduce diagnostic delay in inflammatory bowel disease (ALERT): protocol for a prospective diagnostic studySusann Hasler, Nadine Zahnd, Salomé Müller, et al.
Journal of Gastroenterology and Hepatology|August 17, 2006
Vascular endothelial growth factor secretion from mesenteric adipose tissue and from creeping fat in Crohn's diseaseAndreas Schäffler, Alois Fürst, Christa Büchler, et al.
Inflammatory Intestinal Diseases|June 26, 2025
Long-Term Outcome of Ciclosporin and Infliximab as Rescue Therapy in Steroid-Refractory Acute Severe Ulcerative ColitisFlorian Grob, Isabel Häberling, Gottfried Novacek, et al.
Inflammatory Bowel Diseases|January 13, 2017
Prevalence and Determinants of Job Stress in Patients with Inflammatory Bowel DiseasePhilipp Schreiner, Luc Biedermann, Jean-Benoit Rossel, et al.
Inflammatory Bowel Diseases|March 26, 2015
Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort StudyEkaterina Safroneeva, Stephan R Vavricka, Nicolas Fournier, et al.
Inflammatory Intestinal Diseases|December 1, 2025
An Early Phase 2 Double-Blind, Placebo-Controlled Study of E6011, a Novel Anti-Fractalkine Antibody, in Patients with Crohn's DiseaseTaku Kobayashi, Toshifumi Hibi, Mamoru Watanabe, et al.
Pageof 55

Showing results (151-160 of 547) with videos related to

Sort By:
Pageof 55
Plos One|August 31, 2013
Protein tyrosine phosphatase non-receptor type 22 modulates NOD2-induced cytokine release and autophagyMarianne R Spalinger, Silvia Lang, Stephan R Vavricka, et al.
Digestion|March 16, 2020
Treatment Algorithms for Crohn's DiseaseMichael Christian Sulz, Emanuel Burri, Pierre Michetti, et al.
Inflammatory Bowel Diseases|July 9, 2015
Extraintestinal Manifestations of Inflammatory Bowel DiseaseStephan R Vavricka, Alain Schoepfer, Michael Scharl, et al.
European Journal of Gastroenterology & Hepatology|July 11, 2006
A new organotypic model to study cell interactions in the intestinal mucosaTanja Spottl, Martin Hausmann, Manuela Gunckel, et al.
BMJ Open|March 12, 2015
VAlidation of an 8-item-questionnaire predictive for a positive caLprotectin tEst and Real-life implemenTation in primary care to reduce diagnostic delay in inflammatory bowel disease (ALERT): protocol for a prospective diagnostic studySusann Hasler, Nadine Zahnd, Salomé Müller, et al.
Journal of Gastroenterology and Hepatology|August 17, 2006
Vascular endothelial growth factor secretion from mesenteric adipose tissue and from creeping fat in Crohn's diseaseAndreas Schäffler, Alois Fürst, Christa Büchler, et al.
Inflammatory Intestinal Diseases|June 26, 2025
Long-Term Outcome of Ciclosporin and Infliximab as Rescue Therapy in Steroid-Refractory Acute Severe Ulcerative ColitisFlorian Grob, Isabel Häberling, Gottfried Novacek, et al.
Inflammatory Bowel Diseases|January 13, 2017
Prevalence and Determinants of Job Stress in Patients with Inflammatory Bowel DiseasePhilipp Schreiner, Luc Biedermann, Jean-Benoit Rossel, et al.
Inflammatory Bowel Diseases|March 26, 2015
Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort StudyEkaterina Safroneeva, Stephan R Vavricka, Nicolas Fournier, et al.
Inflammatory Intestinal Diseases|December 1, 2025
An Early Phase 2 Double-Blind, Placebo-Controlled Study of E6011, a Novel Anti-Fractalkine Antibody, in Patients with Crohn's DiseaseTaku Kobayashi, Toshifumi Hibi, Mamoru Watanabe, et al.
Pageof 55